Potential prognostic biomarker includes FBXO32, which correlates with advanced stage and shorter disease free survival (Chou et al., 2010), Ribosomal DNA (18S and 28S) linked with prolonged disease free survival (Chan, 2005), IGFBP-3, correlates with disease progression and death in early stage EOC (Wiley et al., 2006b) and HOXA11, association with postsurgical residual tumor and poor outcome (Fiegl et al., 2008). This evidence concerns the gene FBXO32 and neoplasm.